Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
Clinical trial NCT03523975 · RECRUITING
Trial details
- NCT number
- NCT03523975
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-24
- Primary completion
- 2027-06-24
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.